New quinuclidine amide derivatives having the chemical structure of general formula (I) and pharmaceutically acceptable salts thereof including quaternary salts of formula (II) are disclosed; as well as processes for their preparation, pharmaceutical compositions 10 comprising them and their use in therapy as antagonists of M3 muscarinic receptors.
本研究公开了具有通式(I)
化学结构的新型喹
吖啶酰胺衍
生物及其药学上可接受的盐类,包括式(II)的季盐;以及它们的制备工艺、包含它们的药物组合物10和它们作为M3毒蕈碱受体拮抗剂在治疗中的用途。